Predicting adherence to therapy with glatiramer acetate administered with pre-filled syringes in patients with relapsing-remitting multiple sclerosis

被引：0
|
作者：
Zwibel, H
Pardo, G
Smith, S
Denney, D
机构：
来源：
MULTIPLE SCLEROSIS | 2005年 / 11卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：S83 / S83
页数：1
相关论文
共 50 条
  • [21] Glatiramer acetate in interferon beta non respondent relapsing-remitting multiple sclerosis
    Oreja-Guevara, C.
    Bermejo, P. E.
    Miralles, A.
    Gabaldon, L.
    Aguilar, M. J.
    Diez-Tejedor, E.
    [J]. NEUROLOGIA, 2009, 24 (07): : 435 - 438
  • [22] Glatiramer Acetate 40 mg/mL in Relapsing-Remitting Multiple Sclerosis: A Review
    McKeage, Kate
    [J]. CNS DRUGS, 2015, 29 (05) : 425 - 432
  • [23] Comparative efficacy of interferon β versus glatiramer acetate for relapsing-remitting multiple sclerosis
    La Mantia, Loredana
    Di Pietrantonj, Carlo
    Rovaris, Marco
    Rigon, Giulio
    Frau, Serena
    Berardo, Francesco
    Gandini, Anna
    Longobardi, Anna
    Weinstock-Guttman, Bianca
    Vaona, Alberto
    [J]. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2015, 86 (09): : 1016 - 1020
  • [24] A longitudinal observational study of a cohort of patients with relapsing-remitting multiple sclerosis treated with glatiramer acetate
    Moreau, T.
    Brudon, F.
    Debouverie, M.
    Heinzlef, O.
    Lebrun-Frenay, C.
    Gury, C.
    [J]. MULTIPLE SCLEROSIS, 2006, 12 : S99 - S99
  • [25] Effect of glatiramer acetate on cerebral grey matter pathology in patients with relapsing-remitting multiple sclerosis
    Crescenzo, F.
    Marastoni, D.
    Zuco, C.
    Pitteri, M.
    Magliozzi, R.
    Monaco, S.
    Calabrese, M.
    [J]. MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2019, 27 : 305 - 311
  • [26] Fingolimod versus glatiramer acetate in patients with relapsing-remitting multiple sclerosis - ASSESS study results
    Cree, B. A.
    Goldman, M. D.
    Corboy, J. R.
    Singer, B.
    Fox, E.
    Arnold, D. L.
    Ford, C.
    Weinstock-Guttman, B.
    Bar-or, A.
    Mientus, S.
    Sienkiewicz, D.
    Zhang, Y.
    Karan, R.
    Tenenbaum, N.
    [J]. EUROPEAN JOURNAL OF NEUROLOGY, 2019, 26 : 163 - 163
  • [27] Anaphylactic Reaction after Injection of Glatiramer Acetate (Copaxone®) in Patients with Relapsing-Remitting Multiple Sclerosis
    Baumgartner, Annette
    Stich, Oliver
    Rauer, Sebastian
    [J]. EUROPEAN NEUROLOGY, 2011, 66 (06) : 368 - 370
  • [28] Effect of glatiramer acetate on cerebral grey matter pathology in patients with relapsing-remitting multiple sclerosis
    Crescenzo, F.
    Marastoni, D.
    Zuco, C.
    Pitteri, M.
    Magliozzi, R.
    Monaco, S.
    Calabrese, M.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2018, 24 : 693 - 694
  • [29] A multicenter study of the predictors of adherence to self-injected glatiramer acetate for treatment of relapsing-remitting multiple sclerosis
    Howard Zwibel
    Gabriel Pardo
    Shelly Smith
    Douglas Denney
    MerriKay Oleen-Burkey
    [J]. Journal of Neurology, 2011, 258 : 402 - 411
  • [30] A multicenter study of the predictors of adherence to self-injected glatiramer acetate for treatment of relapsing-remitting multiple sclerosis
    Zwibel, Howard
    Pardo, Gabriel
    Smith, Shelly
    Denney, Douglas
    Oleen-Burkey, MerriKay
    [J]. JOURNAL OF NEUROLOGY, 2011, 258 (03) : 402 - 411
12345